Physiological roles of G protein-coupled receptor kinases and arrestins

Annual Review of Physiology

Volumn 69, Issue , 2007, Pages 511-534

  Premont, Richard T ^a   Gainetdinov, Raul R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; GPCR; GRK; Heart; Immunity; Lung

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CHEMOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE; NEUROTRANSMITTER; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CELL SURFACE; HUMAN GENOME; IMMUNITY; KNOCKOUT MOUSE; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RESPIRATORY SYSTEM; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ARRESTINS; BONE AND BONES; CARDIOVASCULAR PHYSIOLOGY; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM PHYSIOLOGY; NEURONS; PROTEIN-SERINE-THREONINE KINASES; RESPIRATORY PHYSIOLOGY; SIGNAL TRANSDUCTION;

EID: 33947375174     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.69.022405.154731     Document Type: Review

References (130)

1. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3:639-50
2. Luttrell LM. 2005. Composition and function of G protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J. Mol. Neurosci. 26:253-64
3. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by β-arrestins. Science 308:512-17
4. Hausdorff WP, Caron MG, Lefkowitz RJ. 1990. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:2881-89
5. Premont RT. 2005. Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromol. Med. 7:129-47
6. Penn RB, Pronin AN, Benovic JL. 2000. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc. Med. 10:81-89
7. Ferguson SS. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:1-24
8. Penela P, Ribas C, Mayor FJ. 2003. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal 15:973-81
9. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. 2004. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27:107-44
10. Gurevich W, Gurevich EV. 2004. The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci. 25:105-11
11. Gainetdinov RR, Premont RT, Caron MG, Lefkowitz RJ. 2000. Reply: receptor specificity of G-protein-coupled receptor kinases. Trends Pharmacol. Sci. 21:366-7
12. Chen CK. 2002. Recoverin and rhodopsin kinase. Adv. Exp. Med. Biol. 514:101-7
13. Arshavsky VY. 2002. Rhodopsin phosphorylation: from terminating single photon responses to photoreceptor dark adaptation. Trends Neurosci. 25:124-6
14. Maeda T, Imanishi Y, Palczewski K. 2003. Rhodopsin phosphorylation: 30 years later. Prog. Retin. Eye Res. 22:417-34
15. Koch WJ. 2004. Genetic and phenotypic targeting of β-adrenergic signaling in heart failure. Mol. Cell Biochem. 263:5-9
16. Hata JA, Williams ML, Koch WJ. 2004. Genetic manipulation of myocardial β-adrenergic receptor activation and desensitization. J. Mol. Cell Cardiol. 37:11-21
17. Iaccarino G, Koch WJ. 2003. Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. Assay Drug Dev. Technol. 1:347-55
18. Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, et al. 1998. Control of myocardial contractile function by the level of β-adrenergic receptor kinase 1 in gene-targeted mice. J. Biol. Chem. 273:18180-84
19. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, et al. 1996. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. USA 93:12974-79
20. Walker JK, Peppel K, Lefkowitz RJ, Caron MG, Fisher JT. 1999. Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. Am. J. Physiol. 276:R1214-21
21. Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, et al. 1997. β-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ. Res. 81:1021-26
22. Gros R, Tan CM, Chorazyczewski J, Kelvin DJ, Benovic JL, Feldman RD. 1999. G-protein-coupled receptor kinase expression in hypertension. Clin. Pharmacol. Ther. 65:545-51
23. Gros R, Benovic JL, Tan CM, Feldman RD. 1997. G-protein-coupled receptor kinase activity is increased in hypertension. J. Clin. Invest. 99:2087-93
24. Gros R, Chorazyczewski J, Meek MD, Benovic JL, Ferguson SS, Feldman RD. 2000. G-Protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 35:38-42
25. Eckhart AD, Ozaki T, Tevaearai H, Rockman HA, Koch WJ. 2002. Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates β-adrenergic receptor signaling and increases resting blood pressure. Mol. Pharmacol. 61:749-58
26. i-mediated signaling. Circulation 112:1145-53
27. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. 2004. Functional genomics of the dopaminergic system in hypertension. Physiol. Genom. 19:233-46
28. Jose PA, Eisner GM, Felder RA. 1998. Renal dopamine receptors in health and hypertension. Pharmacol. Ther. 80:149-82
29. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, et al. 2002. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl. Acad. Sci. USA 99:3872-77
30. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. 2006. The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol. Pharmacol. 69:759-69
31. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, et al. 2006. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 47:1131-39
32. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, et al. 2006. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin. Chem. 52:352-60
33. Lohmueller KE, Wong LJ, Mauney MM, Jiang L, Felder RA, et al. 2006. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann. Hum. Genet. 70:27-41
34. Gu D, Su S, Ge D, Chen S, Huang J, et al. 2006. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 47:1147-54
35. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. 2005. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat. Med. 11:952-58
36. Liu S, Premont RT, Kontos CD, Huang J, Rockey DC. 2003. Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein βγ subunit signaling to protein kinase B/Akt J. Biol. Chem. 278:49929-35
37. De Blasi A, Parruti G, Sallese M. 1995. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of β-adrenergic receptor kinase 1 and 2. J. Clin. Invest. 95:203-10
38. Loudon RP, Perussia B, Benovic JL. 1996. Differentially regulated expression of the G-protein-coupled receptor kinases, βARK and GRK6, during myelomonocytic cell development in vitro. Blood 88:4547-57
39. Lombardi MS, Kavelaars A, Sehedlowski M, Bijlsma JW, Okihara KL, et al. 1999. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13:715-25
40. Lombardi MS, Kavelaars A, Penela P, Scholtens EJ, Roccio M, et al. 2002. Oxidative stress decreases G protein-coupled receptor kinase 2 in lymphocytes via a calpain-dependent mechanism. Mol. Pharmacol. 62:379-88
41. Lombardi MS, Kavelaars A, Cobelens PM, Schmidt RE, Sehedlowski M, Heijnen CJ. 2001. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J. Immunol. 166:1635-40
42. Vroon A, Lombardi MS, Kavelaars A, Heijnen CJ. 2003. Changes in the G-protein-coupled receptor desensitization machinery during relapsing- progressive experimental allergic encephalomyelitis. J. Neuroimmunol. 137:79-86
43. Oyama N, Urasawa K, Kaneta S, Sakai H, Saito T, et al. 2005. Chronic beta-adrenergic receptor stimulation enhances the expression of G-protein coupled receptor kinases, GRK2 and GRK5, in both the heart and peripheral lymphocytes. Circ. J. 69:987-90
44. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. 2002. Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99:7478-83
45. Kavelaars A, Vroon A, Raatgever RP, Fong AM, Premont RT, et al. 2003. Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. J. Immunol. 171:6128-34
46. Vroon A, Heijnen CJ, Raatgever R, Touw IP, Ploemacher RE, et al. 2004. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo. J. Leukoc. Biol. 75:698-704
47. Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor FJ, et al. 2004. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J. Leukoc. Biol. 75:901-9
48. Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, et al. 2005. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Immunol. 174:4400-6
49. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. 2006. Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7:139-47
50. Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A. 2005. Altered CXCR2 signaling in β-arrestin-2-deficient mouse models. J. Immunol. 175:5396-402
51. Walker JK, Gainetdinov RR, Feldman DS, McFawn PK, Caron MG, et al. 2004. G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L312-19
52. Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, et al. 2003. β-Arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112:566-74
53. Bliziotes M, Murtagh J, Wiren K. 1996. β-adrenergic receptor kinase-like activity and β-arrestin are expressed in osteoblastic cells. J. Bone Miner. Res. 11:820-26
54. Spurney RF, Flannery PJ, Garner SC, Athirakul K, Liu S, et al. 2002. Anabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblasts. J. Clin. Invest. 109:1361-71
55. Wang L, Quarles LD, Spurney RF. 2004. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34). J. Bone Miner. Res. 19:1661-70
56. Bouxsein ML, Pierroz DD, Glatt V, Goddard DS, Cavat F, et al. 2005. β-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J. Bone Miner. Res. 20:635-43
57. Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, et al. 2005. Bone response to intermittent parathyroid hormone is altered in mice null for β-arrestin2. Endocrinology 146:1854-62
58. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, et al. 2003. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA 100:4903-8
59. Zubare-Samuelov M, Shaul ME, Peri I, Aliluiko A, Tirosh O, Nairn M. 2005. Inhibition of signal termination-related kinases by membrane-permeant bitter and sweet tastants: potential role in taste signal termination. Am. J. Physiol. Cell Physiol. 289:C483-92
60. Arriza JL, Dawson TM, Simerly RB, Martin LJ, Caron MG, et al. 1992. The G-protein-coupled receptor kinases βARK1 and βARK2 are widely distributed at synapses in rat brain. J. Neurosci. 12:4045-55
61. Erdtmann-Vourliotis M, Mayer P, Amnon S, Riechert U, Hollt V. 2001. Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Br. Res. Mol. Br. Res. 95:129-37
62. Penela P, Alvarez-Dolado M, Munoz A, Mayor FJ. 2000. Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and β-arrestin 1 during rat postnatal brain development: effect of hypothyroidism. Eur. J. Biochem. 267:4390-96
63. Grange-Midroit M, Garcia-Sevilla JA, Ferrer-Alcon M, La Harpe R, Huguelet P, Guimon J. 2003. Regulation of GRK 2 and 6, β-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Br. Res. Mol. Br. Res. 111:31-41
64. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. 2003. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc. Natl. Acad, Sci. USA 100:313-17
65. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. 2002. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J. Neurosci. 22:8476-86
66. Bezard E, Gross CE, Qin L, Gurevich VV, Benovic JL, Gurevich EV. 2005. L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol. Dis. 18:323-35
67. Terwilliger RZ, Ortiz J, Guitart X, Nestler EJ. 1994. Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J. Neurochem. 63:1983-86
68. Ozaita A, Escriba PV, Ventayol P, Murga C, Mayor FJ, Garcia-Sevilla JA. 1998. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J. Neurochem. 70:1249-57
69. Hurle MA. 2001. Changes in the expression of G protein-coupled receptor kinases and β-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J. Neurochem. 77:486-92
70. Diaz A, Pazos A, Florez J, Ayesta FJ, Santana V, Hurle MA. 2002. Regulation of μ-opioid receptors, G-protein-coupled receptor kinases and β-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience 112:345-53
71. Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, et al. 2006. μ-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to μ-opioid receptor agonists: comparison between etorphine and morphine. Neuroscience 138:609-19
72. Li AH, Wang HL. 2001. G protein-coupled receptor kinase 2 mediates μ-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J. Neurochem. 77:435-44
73. Fan X, Zhang J, Zhang X, Yue W, Ma L. 2002. Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology 43:809-16
74. Ammon-Treiber S, Hollt V. 2005. Morphine-induced changes of gene expression in the brain. Addict. Biol. 10:81-89
75. Bohn LM, Gainetdinov RR, Caron MG. 2004. G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. Neuromol. Med. 5:41-50
76. Pronin AN, Morris AJ, Surguchov A, Benovic JL. 2000. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275:26515-22
77. Suo Z, Wu M, Citron BA, Wong GT, Festoff BW. 2004. Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early β-amyloid accumulation. J. Neurosci. 24:3444-52
78. Lombardi MS, van den Tweel E, Kavelaars A, Groenendaal F, van Bel F, Heijnen CJ. 2004. Hypoxia/ischemia modulates G protein-coupled receptor kinase 2 and β-arrestin-1 levels in the neonatal rat brain. Stroke 35:981-86
79. Willets JM, Nahorski SR, Challiss RA. 2005. Roles of phosphorylation- dependent and -independent mechanisms in the regulation of M1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons. J. Biol. Chem. 280:18950-58
80. Kageyama K, Hanada K, Moriyama T, Nigawara T, Sakihara S, Suda T. 2006. G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs. Endoainology 147:441-50
81. Boekhoff I, Inglese J, Schleicher S, Koch WJ, Lefkowitz RJ, Breer H. 1994. Olfactory desensitization requires membrane targeting of receptor kinase mediated by βγ-subunits of heterotrimeric G proteins. J. Biol. Chem. 269:37-40
82. 2+ channel inhibition. Neuron 16:579-85
83. Peppel K, Boekhoff I, McDonald P, Breer H, Caron MG, Lefkowitz RJ. 1997. G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J. Biol. Chem. 272:25425-28
84. Niculescu AB, Segal DS, Kuczenski R, Barrett T, Hauger RL, Kelsoe JR. 2000. Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol. Genom. 4:83-91
85. Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, et al. 2003. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol. Psychiat. 8:546-57
86. Shaltiel G, Shamir A, Levi I, Bersudsky Y, Again G. 2006. Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder. Int. J. Neuropsychopharmacol. 9:761-66 doi: 10.1017/S146114570500636X
87. Yu SY, Takahashi S, Arinami T, Ohkubo T, Nemoto Y, et al. 2004. Mutation screening and association study of the β-adrenergic receptor kinase 2 gene in schizophrenia families. Psychiat. Res. 125:95-104
88. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401
89. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS. 2005. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-β-arrestin complex. A case of autoreceptor regulation. J. Biol. Chem. 280:12774-80
90. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, et al. 2004. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br. J. Pharmacol. 141:55-64
91. Xu M, Petraschka M, McLaughlin JP, Westenbroek RE, Caron MG, et al. 2004. Neuropathic pain activates the endogenous K opioid system in mouse spinal cord and induces opioid receptor tolerance. J. Neurosci. 24:4576-84
92. McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, et al. 2004. Prolonged K opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J. Biol. Chem. 279:1810-18
93. Sallese M, Salvatore L, D'Urbano E, Sala G, Storto M, et al. 2000. The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J. 14:2569-80
94. Iacovelli L, Salvatore L, Capobianco L, Picascia A, Barletta E, et al. 2003. Role of G protein-coupled receptor kinase 4 and β-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J. Biol. Chem. 278:12433-42
95. Perroy J, Adam L, Qanbar R, Chenier S, Bouvier M. 2003. Phosphorylation-independent desensitization of GABA(B) receptor by GRK4. EMBO J. 22:3816-24
96. Gurevich EV, Benovic JL, Gurevich VV. 2004. Arrestin2 expression selectively increases during neural differentiation. J. Neurochem. 91:1404-16
97. Gainetdinov RR, Bohn LM, Walker JK, Laporte SA, Macrae AD, et al. 1999. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24:1029-36
98. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, et al. 1999. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 96:1692-97
99. Fehr C, Fickova M, Hiemke C, Reuss S, Dahmen N. 1997. Molecular cloning of rat G-protein-coupled receptor kinase 6 (GRK6) from brain tissue, and its mRNA expression in different brain regions and peripheral tissues. Br. Res. Mol. Br. Res. 49:278-82
100. Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, et al. 2003. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38:291-303
101. Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR. 2004. Dopamine transporter-dependent and -independent actions of trace amine β-phenylethylamine. J. Neurochem. 91:362-73
102. Premont RT, Gainetdinov RR, Caron MG. 2001. Following the trace of elusive amines. Proc. Natl. Acad. Sci. USA 98:9474-75
103. Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, et al. 2005. Dopamine supersensitivity correlates with D2 high states, implying many paths to psychosis. Proc. Natl. Acad. Sci. USA 102:3513-18
104. Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA. 2004. Decreased immunodensities of μ-opioid receptors, receptor kinases GRK 2/6 and β-arrestin-2 in postmortem brains of opiate addicts. Br. Res. Mol. Br. Res. 121:114-22
105. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, et al. 1992. β-Arrestin2, a novel member of the arrestin/β-arrestin gene family. J. Biol. Chem. 267:17882-90
106. Parruti G, Ambrosini G, Sallese M, De Blasi A. 1993. Molecular cloning, functional expression and mRNA analysis of human β-adrenergic receptor kinase 2. Biochem. Biophys. Res. Commun. 190:475-81
107. Gurevich EV, Benovic JL, Gurevich W. 2002. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109:421-36
108. Kittel A, Komori N. 1999. Ultrastructural localization of β-arrestin-1 and -2 in rat lumbar spinal cord. J. Comp. Neurol. 412:649-55
109. Fan XL, Zhang JS, Zhang XQ, Yue W, Ma L. 2003. Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine. Neuroscience 117:383-89
110. Avissar S, Matuzany-Ruban A, Tzukert K, Schreiber G. 2004. β-Arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am. J. Psychiat. 161:2066-72
111. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Dun NJ, Tseng LF. 2003. Involvement of β-arrestin-2 in modulation of the spinal antinociception induced by μ-opioid receptor agonists in the mouse. Neurosci. Lett. 346:13-16
112. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, et al. 1998. Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95:7157-62
113. Whistler JL, von Zastrow M. 1998. Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc. Natl. Acad. Sci. USA 95:9914-19
114. Kovoor A, Celver JP, Wu A, Chavkin C. 1998. Agonist induced homologous desensitization of μ-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol. Pharmacol. 54:704-11
115. Haberstock-Debic H, Kim KA, Yu YJ, von Zastrow M. 2005. Morphine promotes rapid, arrestin-dependent endocytosis of μ-opioid receptors in striatal neurons. J. Neurosci. 25:7847-57
116. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. 1999. Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286:2495-98
117. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. 2000. μ-opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-23
118. Beaulieu JM. 2005. Morphine-induced μ-opioid receptor internalization: a paradox solved in neurons. J. Neurosci. 25:10061-63
119. Bohn LM, Lefkowitz RJ, Caron MG. 2002. Differential mechanisms of morphine antinociceptive tolerance revealed in βarrestin-2 knock-out mice. J. Neurosci. 22:10494-500
120. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS. 2004. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol. Pharmacol. 66:106-12
121. Raehal KM, Walker JK, Bohn LM. 2005. Morphine side effects in β-arrestin 2 knockout mice. J. Pharmacol. Exp. Ther. 314:1195-201
122. Jiang B, Shi Y, Li H, Kang L, Ma L. 2006. Decreased morphine analgesia in rat overexpressing β-arrestin 2 at periaqueductal gray. Neurosci. Lett. 400:150-53
123. Hack SP, Bagley EE, Chieng BC, Christie MJ. 2005. Induction of δ-opioid receptor function in the midbrain after chronic morphine treatment. J. Neurosci. 25:3192-98
124. Bradaia A, Berton F, Ferrari S, Luscher C. 2005. β-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids. Proc. Natl. Acad. Sci. USA 102:3034-39
125. Elmer GI, Pieper JO, Rubinstein M, Low MJ, Grandy DK, Wise RA. 2002. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J. Neurosci. 22:RC224
126. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, et al. 2003. Enhanced rewarding properties of morphine, but not cocaine, in βarrestin-2 knock-out mice. J. Neurosci. 23:10265-73
127. Tao R, Auerbach SB. 1995. Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 68:553-61
128. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-73
129. Gainetdinov RR, Caron MG. 2003. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43:261-84
130. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, et al. 2004. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. USA 101:5099-104